ProPublica studied five different specialties to compare the rates by which doctors who receive money from big pharma prescribe typically more expensive brand name medication, versus doctors who haven’t taken money from pharma. The analysis found that doctors who receive $5,000 or more from pharmaceutical companies in a given year all prescribe more brand name… Read More
Pfizer has recently agreed to pay $330 million dollars to settle more than 2,200 lawsuits charging that Prempro caused women to develop Breast Cancer. Overview Prempro, also known as conjugated estrogen/medroxyprogesterone acetate, was approved by the U.S. Food and Drug Administration (FDA) in November 1995, to relieve menopause symptoms and osteoporosis. It is a combination… Read More
An article published in November in BioMed Central discovered serious differences between studies funded by pharmaceutical companies selling testosterone therapy drugs, and those that were independent of pharmaceutical companies pushing the drugs. Combined with the FDA warning1 in January on the risks of testosterone therapy, including heart attacks and strokes, this paints a troubling picture… Read More
Earlier this year, a group of private companies and institutions released a new mobile application in collaboration with the Food and Drug Administration Center for Devices and Radiologic Health. It is called MedWatcher, and is a mobile app for use on tablets and smartphones to make reporting negative effects of drugs, medical devices, and vaccines… Read More
After over 1000 adverse event reports, several consumer watchdog groups have urged diabetics to avoid using Actos or its generic equivalent. Many have espoused that actos use may not be worth the associated health risks. A group by the name of “Consumer Reports” noted that Actos should only be used as a “last resort” diabetes… Read More